ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,248, issued on Dec. 30, was assigned to SEREN PHARMACEUTICALS INC. (Tokyo) and NIHON UNIVERSITY (Tokyo).
"Therapeutic agent for prototheca disease" was invented by Rui Kano (Tokyo) and Osamu Ogawa (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention has an object of providing a composition that is effective for the treatment of a prototheca disease. According to the present invention, a composition containing ravuconazole as an active ingredient, which is administered to an animal suffering from a prototheca disease caused by Prototheca wickerhamii or Prototheca zopfii, is provided."
The patent was filed on July 9, 2020, unde...